Optimize Your RWE Investments Through a Platform-Based Approach

This Solution Provider Webinar is brought to you by DIA in cooperation with CitiusTech.

In this webinar...

With the increasing drug development cost, shift from volume to value-based pricing and competition from generics and biosimilars, pharma and life science organizations are looking towards real world evidence (RWE) to prove the value – cost, safety, and effectiveness of their medicinal products. However, the current real-world data comes in structured and unstructured format, in various data standards, and is laden with varied data quality issues. The industry is looking to define a platform-based approach to address the functional and technical complexities of RWE and harness the real-world datasets across the pharma value chain.

Learning Objectives

  • Understand the key business use cases and stakeholders of RWE
  • Gather an industry perspective on RWE and its impact on entire pharma value chain
  • Understand the current state of RWE analytics implementation and associated complexity
  • Get an overview of a platform-based approach to harness real-world datasets for observation research


  • Jim Carroll, MBA, Vice President (RWE), ICON
  • Jeffrey Springer, MBA, Vice President, CitiusTech Inc.